Article ; Online: Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase.
British journal of pharmacology
2010 Volume 159, Issue 7, Page(s) 1542–1547
Abstract: Background and purpose: Soluble guanylate cyclase (sGC) is the signal transduction enzyme most responsible for mediating the effects of nitric oxide (NO). Recently, NO-independent small molecule activators of sGC have been developed that have promising ... ...
| Abstract | Background and purpose: Soluble guanylate cyclase (sGC) is the signal transduction enzyme most responsible for mediating the effects of nitric oxide (NO). Recently, NO-independent small molecule activators of sGC have been developed that have promising clinical activities. We have shown that the secreted matrix protein thrombospondin-1 (TSP-1) binds to CD47 and potently inhibits NO stimulation of sGC in endothelial and vascular smooth muscle cells (VSMCs) and platelets. Here we show that TSP-1 signalling via CD47 inhibits sGC activation by NO-independent sGC activating small molecules. Experimental approach: Vascular smooth muscle cells and washed human platelets were pretreated with TSP-1 (2.2 nM) in the presence of haeme-dependent sGC activators (YC-1, BAY 41-2272), and a haeme-independent activator (meso-porphyrin IX), and cGMP levels were measured. The effect of sGC activators on platelet aggregation and contraction of VSMC embedded in collagen gels was also assayed in the presence and absence of TSP-1. Key results: Thrombospondin-1 inhibited sGC activator-dependent increase in cGMP in VSMC and platelets. TSP-1 pretreatment also inhibited the ability of these agents to delay thrombin-induced platelet aggregation. TSP-1 pretreatment reduced the ability of sGC activating agents to abrogate VSMC contraction in vitro. Conclusions and implications: This work demonstrates that TSP-1 is a universal inhibitor of sGC, blocking both haeme-dependent and haeme-independent activation. These data coupled with the reported increases in TSP-1 with age, diabetes, ischaemia/reperfusion, and atherosclerosis implies that the therapeutic potential of all drugs that activate sGC could be compromised in disease states where TSP-1/CD47 signalling is elevated. |
|---|---|
| MeSH term(s) | Blood Platelets/drug effects ; Blood Platelets/enzymology ; Cells, Cultured ; Cyclic GMP/metabolism ; Enzyme Activation ; Enzyme Activators/pharmacology ; Guanylate Cyclase/antagonists & inhibitors ; Guanylate Cyclase/metabolism ; Humans ; Muscle, Smooth, Vascular/cytology ; Muscle, Smooth, Vascular/drug effects ; Muscle, Smooth, Vascular/enzymology ; Platelet Aggregation ; Thrombospondin 1/pharmacology |
| Chemical Substances | Enzyme Activators ; Thrombospondin 1 ; Guanylate Cyclase (EC 4.6.1.2) ; Cyclic GMP (H2D2X058MU) |
| Language | English |
| Publishing date | 2010-04 |
| Publishing country | England |
| Document type | Journal Article ; Research Support, N.I.H., Extramural |
| ZDB-ID | 80081-8 |
| ISSN | 1476-5381 ; 0007-1188 |
| ISSN (online) | 1476-5381 |
| ISSN | 0007-1188 |
| DOI | 10.1111/j.1476-5381.2009.00631.x |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Uf I Zs.146: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.